Two awards for Living Networks: IChF-originated technology recognized in the Polish Product of the Future competition

Reading time: about 3 minuts

Two awards for Living Networks: IChF-originated technology recognized in the Polish Product of the Future competition

Living Networks, a biotechnology company developing technology that originated at the Institute of Physical Chemistry, Polish Academy of Sciences (IChF), has received two awards in the 27th Polish Product of the Future competition, organized by the Polish Agency for Enterprise Development (PARP). Its vascularized human tissue models won the PLN 100,000 grand prize in the Future Product by an Entrepreneur category, along with a special award for a product submitted by a young entrepreneur.

The awards were presented on October 20, 2026, at a ceremony in Warsaw. The competition recognizes innovative technologies developed by Polish research institutions and businesses, with particular emphasis on their potential for practical applications.

More faithful human tissue models for more reliable drug testing

One of the challenges in modern drug development is creating laboratory models that closely reproduce the complexity of human tissues while remaining reproducible, standardized, and suitable for large-scale testing. Conventional cell cultures cannot fully capture the complexity of tissue environments, while more sophisticated models can be difficult to automate and reproduce consistently.

Living Networks is addressing this challenge through its VTμA (Vascularized Tissue microArray) platform, which enables the assembly of ultra-miniaturized, three-dimensional human tissue models containing networks of microscopic blood vessels.

The technology uses a proprietary magnetic microcarrier approach to organize endothelial cells into controlled vascular structures. By combining physiologically relevant tissue features with miniaturization and automation, the platform is designed to make vascularized tissue models more reproducible and accessible for preclinical research.

A key advantage is its compatibility with standard multiwell plate formats, allowing researchers to conduct multiple tests in parallel while using relatively small amounts of cells and reagents. Proprietary software also supports automated morphological measurements, helping standardize data analysis and reduce operator-dependent variability.

Applications in drug development and disease modeling

The platform has potential applications in studies of blood vessel formation, vascular toxicity, and the effects of compounds that promote or inhibit angiogenesis.

By recreating selected features of human tissue microenvironments, these models could help researchers evaluate drug candidates earlier in development, identify compounds with undesirable effects, and reduce reliance on certain animal experiments.

Living Networks is currently focusing on applications involving cancer models, including breast, lung, and cervical cancer. The company is also developing preclinical screening services for pharmaceutical and biotechnology research.

From IChF research to biotechnology innovation

Research on the award-winning technology began at IChF in 2020, initially through scientific research projects. In 2024, Dr. Jan Guzowski and Dr. Katarzyna Rojek founded Living Networks to advance the technology toward practical applications.

The company is now moving from research and development toward commercialization. An important next step is demonstrating the platform's value across different drug testing applications and generating the evidence needed for broader industrial adoption.

The two awards recognize the team's scientific and technological achievements while highlighting the broader importance of research translation. Advanced research conducted in academic laboratories can provide the foundation for new technologies capable of addressing important challenges in medicine.

“From dreams to solutions” – IChF's motto reflects this journey: from an ambitious scientific concept, through sustained research and development, to technologies with the potential to make an impact beyond the laboratory.

Congratulations to Dr. Jan Guzowski, Dr. Katarzyna Rojek, and the entire Living Networks team on both awards. We wish them continued success as they advance the technology toward practical applications.

Read more:

Polish Agency for Enterprise Development – winners of the 27th Polish Product of the Future competition: https://www.parp.gov.pl/component/content/article/91387:wyloniono-najlepsze-polskie-innowacje-znamy-laureatow-polskiego-produktu-przyszlosci

  • Photo source: Photos: Polish Product of the Future award ceremony; courtesy of Living Networks.
  • Date: 16.11.2026